These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 10774524)
41. [Muscle and tendon problems as a side-effect of levofloxacine: review of a case]. Vergara Fernández I Aten Primaria; 2004 Mar; 33(4):214. PubMed ID: 15023326 [No Abstract] [Full Text] [Related]
42. Shiga toxin-producing Escherichia coli urinary tract infection associated with hemolytic-uremic syndrome in an adult and possible adverse effect of ofloxacin therapy. Miedouge M; Hacini J; Grimont F; Watine J Clin Infect Dis; 2000 Feb; 30(2):395-6. PubMed ID: 10671349 [No Abstract] [Full Text] [Related]
43. A rare case of facial annular bullous erythema nodosum leprosum reaction in a young boy. Goyal T; Varshney A; Sharma V; Zawar V Int J Dermatol; 2016 Jun; 55(6):e368-71. PubMed ID: 26748548 [No Abstract] [Full Text] [Related]
44. Acute hepatitis associated with oral levofloxacin therapy in a hemodialysis patient. Schwalm JD; Lee CH CMAJ; 2003 Apr; 168(7):847-8. PubMed ID: 12668542 [TBL] [Abstract][Full Text] [Related]
45. Cough... followed by calf pain. London L Adv Nurse Pract; 2007 Jul; 15(7):21-2. PubMed ID: 19998990 [No Abstract] [Full Text] [Related]
46. Randomized, double-blind, comparative study of levofloxacin and ofloxacin in the treatment of complicated urinary tract infections. Peng MY J Microbiol Immunol Infect; 1999 Mar; 32(1):33-9. PubMed ID: 11561568 [TBL] [Abstract][Full Text] [Related]
47. Acute hepatitis associated with levofloxacin in a patient with renal insufficiency. Airey K; Koller E CMAJ; 2003 Oct; 169(8):755. PubMed ID: 14557312 [No Abstract] [Full Text] [Related]
48. Unexpected, severe central nerve system toxicity of ofloxacine: report of two cases. Guven EO; Balbay D; Kilciler M Int Urol Nephrol; 2007; 39(2):647-9. PubMed ID: 17268904 [TBL] [Abstract][Full Text] [Related]
49. [Levofloxacin and bilateral spontaneous Achilles tendon rupture]. Bernácer L; Artigues A; Serrano A Med Clin (Barc); 2003 Jan; 120(2):78-9. PubMed ID: 12570920 [No Abstract] [Full Text] [Related]
50. [Levofloxacin and acute confusional syndrome]. Pedrós A; Emilio Gómez J; Angel Navarro L; Tomás A Med Clin (Barc); 2002 Jun; 119(1):38-9. PubMed ID: 12062009 [No Abstract] [Full Text] [Related]
51. [Side effects of fluoroquinolones. Safety and tolerability of levofloxacin in clinical practice]. Nikitin AV; Litovchenko KV Antibiot Khimioter; 2002; 47(4):20-3. PubMed ID: 12369140 [No Abstract] [Full Text] [Related]
52. A phase III clinical trial of 0.5% levofloxacin ophthalmic solution versus 0.3% ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Schwab IR; Friedlaender M; McCulley J; Lichtenstein SJ; Moran CT; Ophthalmology; 2003 Mar; 110(3):457-65. PubMed ID: 12623805 [TBL] [Abstract][Full Text] [Related]
53. [Levofloxacin adverse effects, data from clinical trials and pharmacovigilance]. Carbon C Therapie; 2001; 56(1):35-40. PubMed ID: 11322015 [TBL] [Abstract][Full Text] [Related]
55. Neuropsychiatric complications following quinolone overdose in renal failure. Bagon JA Nephrol Dial Transplant; 1999 May; 14(5):1337. PubMed ID: 10344402 [No Abstract] [Full Text] [Related]
56. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)]. Scheen AJ Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704 [TBL] [Abstract][Full Text] [Related]